Daisuke Tamura

3.5k total citations
67 papers, 1.9k citations indexed

About

Daisuke Tamura is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Daisuke Tamura has authored 67 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Daisuke Tamura's work include Lung Cancer Treatments and Mutations (10 papers), Congenital limb and hand anomalies (5 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Daisuke Tamura is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Congenital limb and hand anomalies (5 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Daisuke Tamura collaborates with scholars based in Japan, United States and Czechia. Daisuke Tamura's co-authors include Toshiyuki Yoneda, Toru Hiraga, Paul J. Williams, Hiroyasu Kaneda, Yoshihiko Fujita, Kazuto Nishio, Keiichi Aomatsu, Tokuzo Arao, Kanae Kudo and Kaoru Tanaka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Daisuke Tamura

61 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisuke Tamura Japan 23 904 756 564 305 202 67 1.9k
Arlene Berman United States 22 1.3k 1.4× 614 0.8× 474 0.8× 534 1.8× 284 1.4× 47 2.4k
Shi‐Ming Tu United States 19 781 0.9× 857 1.1× 1.1k 1.9× 397 1.3× 206 1.0× 72 2.1k
Yoshio Tomizawa Japan 24 1.1k 1.2× 1.1k 1.5× 991 1.8× 383 1.3× 114 0.6× 72 2.2k
Vladimir Bilim Japan 25 583 0.6× 1.4k 1.8× 475 0.8× 397 1.3× 134 0.7× 81 2.1k
Yong Wha Moon South Korea 22 918 1.0× 658 0.9× 685 1.2× 335 1.1× 113 0.6× 69 1.8k
Charles LeVea United States 24 997 1.1× 720 1.0× 321 0.6× 180 0.6× 326 1.6× 71 1.8k
Élodie Vauléon France 24 596 0.7× 522 0.7× 414 0.7× 302 1.0× 132 0.7× 60 1.8k
Nadia Dandachi Austria 23 799 0.9× 565 0.7× 215 0.4× 508 1.7× 181 0.9× 57 1.5k
Brian J. Yoder United States 18 670 0.7× 460 0.6× 318 0.6× 290 1.0× 174 0.9× 22 1.4k
Ingeborg Tinhofer Germany 26 1.4k 1.6× 872 1.2× 629 1.1× 848 2.8× 138 0.7× 77 2.5k

Countries citing papers authored by Daisuke Tamura

Since Specialization
Citations

This map shows the geographic impact of Daisuke Tamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Tamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Tamura more than expected).

Fields of papers citing papers by Daisuke Tamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Tamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Tamura. The network helps show where Daisuke Tamura may publish in the future.

Co-authorship network of co-authors of Daisuke Tamura

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Tamura. A scholar is included among the top collaborators of Daisuke Tamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Tamura. Daisuke Tamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Katsurada, Naoko, Motoko Tachihara, Tatsunori Kiriu, et al.. (2020). <p>Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC</p>. Cancer Management and Research. Volume 12. 777–782. 4 indexed citations
3.
Maeda, Daichi, Daisuke Tamura, Kenichi Makino, et al.. (2020). Detection of MED12 mutations in mesenchymal components of uterine adenomyomas. Human Pathology. 109. 31–36. 1 indexed citations
4.
Katsurada, Naoko, Naoe Jimbo, Motoko Tachihara, et al.. (2019). Overexpression of CD 133 and BCL‐2 in non‐small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement‐positive adenocarcinoma. Pathology International. 69(5). 294–299. 14 indexed citations
5.
Katsurada, Masahiro, Tatsuya Nagano, Motoko Tachihara, et al.. (2019). Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer. Anticancer Research. 39(2). 815–825. 74 indexed citations
6.
Kiriu, Tatsunori, Masatsugu Yamamoto, Tatsuya Nagano, et al.. (2018). The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer. PLoS ONE. 13(2). e0193018–e0193018. 60 indexed citations
7.
Goto, Masahide, et al.. (2018). Rotavirus gastroenteritis-associated urinary tract calculus in an infant. The Turkish Journal of Pediatrics. 60(6). 769–770. 4 indexed citations
8.
Li, Zhuo, Daichi Maeda, Daisuke Tamura, et al.. (2018). MED12 is frequently mutated in ovarian and other adnexal leiomyomas. Human Pathology. 81. 89–95. 10 indexed citations
9.
Kiriu, Tatsunori, Masatsugu Yamamoto, Tatsuya Nagano, et al.. (2018). Prognostic Value of Red Blood Cell Distribution Width in Non-small Cell Lung Cancer Treated With Anti-programmed Cell Death-1 Antibody. In Vivo. 33(1). 213–220. 15 indexed citations
10.
Nanjo, Shigeki, Akito Hata, Chiyuki Okuda, et al.. (2017). Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer. British Journal of Cancer. 118(1). 32–37. 69 indexed citations
11.
Kunimasa, Kei, Tatsuya Nagano, Yohei Shimono, et al.. (2017). Glucose metabolism‐targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor‐induced drug‐tolerant persisters. Cancer Science. 108(7). 1368–1377. 27 indexed citations
12.
Maeda, Daichi, Daisuke Tamura, Tsutomu Sato, et al.. (2017). Fetal gut–like differentiation in gallbladder cancer. Human Pathology. 70. 27–34. 6 indexed citations
13.
Nagai, Tomoyuki, Tokuzo Arao, Kazuto Nishio, et al.. (2016). Impact of Tight Junction Protein ZO-1 and TWIST Expression on Postoperative Survival of Patients with Hepatocellular Carcinoma. Digestive Diseases. 34(6). 702–707. 17 indexed citations
14.
Kawabata, Hidehiko, et al.. (2016). Focal fibrocartilaginous dysplasia in the ulna with the radial head dislocation: a case report and literature review. Journal of Pediatric Orthopaedics B. 26(1). 41–47. 4 indexed citations
15.
Kobayashi, Kazuyuki, Tatsuya Nagano, Daisuke Tamura, et al.. (2013). Synergistic effects of pemetrexed and amrubicin in non-small cell lung cancer cell lines: Potential for combination therapy. Cancer Letters. 343(1). 74–79. 20 indexed citations
16.
Nagai, Tomoyuki, Tokuzo Arao, Kazuyuki Furuta, et al.. (2011). Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 10(1). 169–177. 101 indexed citations
17.
Okamoto, Nobuhiko, Daisuke Tamura, Gen Nishimura, Keiko Shimojima, & Toshiyuki Yamamoto. (2011). Submicroscopic deletion of 12q13 including HOXC gene cluster with skeletal anomalies and global developmental delay. American Journal of Medical Genetics Part A. 155(12). 2997–3001. 7 indexed citations
18.
Kaneda, Hiroyasu, Tokuzo Arao, Kaoru Tanaka, et al.. (2010). FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth. Cancer Research. 70(5). 2053–2063. 157 indexed citations
19.
Kudo, Kanae, Tokuzo Arao, Kaoru Tanaka, et al.. (2010). Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In Vivo. Clinical Cancer Research. 17(6). 1373–1381. 31 indexed citations
20.
Matsumoto, Kunio, Tokuzo Arao, Kaoru Tanaka, et al.. (2009). mTOR Signal and Hypoxia-Inducible Factor-1α Regulate CD133 Expression in Cancer Cells. Cancer Research. 69(18). 7160–7164. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arlene Berman Breakdown of academic impact, for papers by Shi‐Ming Tu Breakdown of academic impact, for papers by Yoshio Tomizawa Breakdown of academic impact, for papers by Vladimir Bilim Breakdown of academic impact, for papers by Yong Wha Moon Breakdown of academic impact, for papers by Charles LeVea Breakdown of academic impact, for papers by Élodie Vauléon Breakdown of academic impact, for papers by Nadia Dandachi Breakdown of academic impact, for papers by Brian J. Yoder Breakdown of academic impact, for papers by Ingeborg Tinhofer
Rankless by CCL
2026